Neuroleptic malignant syndrome in a COVID-19 patient
نویسندگان
چکیده
منابع مشابه
Olanzapine-Induced Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics. Although NMS is less common with atypical antipsychotic, but it seems that its incidence is rising due to increased administration of such drug...
متن کاملNeuroleptic malignant syndrome in an elderly patient.
The incidence of neonatal septicaemia caused by group B streptococci in our hospital during 1980-6 was 9 1/10 000 births, which is three times higher than the average rate in the United Kingdom.2 Despite this, mortality during this period was only 5% (one death in 20 cases), which is one seventh the national average of 36%1; we ascribe this to the early antibiotic treatment of neonates with tac...
متن کاملEndovascular cooling in a patient with neuroleptic malignant syndrome.
We report a case of severe neuroleptic malignant syndrome with hyperthermia, rhabdomyolysis and hepatic failure where we applied endovascular cooling in order to reverse hyperthermia. After rapid normalization of core temperature at 37.5 degrees C, the patient's condition improved and CK levels dropped. However, upon withdrawl of endovascular temperature control there was a relapse. This is the...
متن کاملAtypical Presentation of Neuroleptic Malignant Syndrome in a Pediatric Patient
This is a case of a 16-year-old male with a history of attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), obsessive compulsive disorder (OCD), and bipolar disorder (BD) who presented to the emergency department with hypertension, tachycardia, rigidity, and altered mental status 2 months after the initiation of olanzapine. Symptoms were most consistent with Neu...
متن کاملNeuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration
Parkinson's disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed NMS after abrupt reduction of antiparkinsonian medication and concurrent infection. It should be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Brain, Behavior, and Immunity
سال: 2020
ISSN: 0889-1591
DOI: 10.1016/j.bbi.2020.05.042